share_log

Terns Pharma Q4 2024 GAAP EPS $(0.24) Beats $(0.30) Estimate

Benzinga ·  Mar 20 20:17

Terns Pharma (NASDAQ:TERN) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.30) by 20 percent. This is a 17.24 percent increase over losses of $(0.29) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 369

Recommended

Write a comment